Simplex Trading
JAZZ icon

Simplex Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History

Simplex Trading’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.21M Sell
6,400
-9,700
-60% -$1.7M ﹤0.01% 2302
2025
Q4 		$2.74M Sell
16,100
-3,000
-16% -$460K ﹤0.01% 1728
2025
Q3 		$2.52M Buy
19,100
+6,800
+55% +$816K ﹤0.01% 2098
2025
Q2 		$1.3M Buy
12,300
+6,400
+108% +$695K ﹤0.01% 2505
2025
Q1 		$732K Buy
5,900
+3,300
+127% +$431K ﹤0.01% 3000
2024
Q4 		$320K Sell
2,600
-4,400
-63% -$519K ﹤0.01% 4002
2024
Q3 		$779K Sell
7,000
-5,900
-46% -$647K ﹤0.01% 3154
2024
Q2 		$1.38M Buy
12,900
+5,700
+79% +$627K ﹤0.01% 2575
2024
Q1 		$867K Sell
7,200
-4,600
-39% -$563K ﹤0.01% 3268
2023
Q4 		$1.45M Sell
11,800
-5,100
-30% -$636K ﹤0.01% 2649
2023
Q3 		$2.19M Buy
16,900
+6,500
+63% +$866K ﹤0.01% 1998
2023
Q2 		$1.29M Buy
10,400
+300
+3% +$40.4K ﹤0.01% 2366
2023
Q1 		$1.48M Buy
10,100
+7,200
+248% +$1.07M ﹤0.01% 2209
2022
Q4 		$446K Sell
2,900
-8,100
-74% -$1.19M ﹤0.01% 3274
2022
Q3 		$1.47M Buy
11,000
+6,900
+168% +$1.05M ﹤0.01% 2261
2022
Q2 		$639K Sell
4,100
-1,000
-20% -$154K ﹤0.01% 3158
2022
Q1 		$793K Sell
5,100
-2,400
-32% -$348K ﹤0.01% 3204
2021
Q4 		$955K Sell
7,500
-14,900
-67% -$1.96M ﹤0.01% 2916
2021
Q3 		$4.06M Sell
22,400
-300
-1% -$45.3K ﹤0.01% 1387
2021
Q2 		$4.03M Buy
22,700
+22,438
+8,564% +$3.89M ﹤0.01% 1382
2021
Q1 		$4.31M Buy
262
+186
+245% +$30.6K 0.01% 942
2020
Q4 		$1.25M Sell
76
-78
-51% -$11.6K ﹤0.01% 2267
2020
Q3 		$2.19M Buy
154
+121
+367% +$15K ﹤0.01% 1451
2020
Q2 		$364K Sell
33
-110
-77% -$12.2K ﹤0.01% 3287
2020
Q1 		$1.43M Sell
143
-66
-32% -$8.53K ﹤0.01% 1559
2019
Q4 		$3.12M Buy
209
+59
+39% +$8.03K 0.01% 1122
2019
Q3 		$1.92M Buy
150
+13
+9% +$1.74K 0.01% 1363
2019
Q2 		$1.95M Sell
137
-103
-43% -$13.8K 0.01% 1331
2019
Q1 		$3.43M Buy
240
+161
+204% +$21K 0.01% 945
2018
Q4 		$979K Buy
79
+30
+61% +$4.45K ﹤0.01% 1646
2018
Q3 		$823K Sell
49
-43
-47% -$7.39K ﹤0.01% 2087
2018
Q2 		$1.58M Buy
92
+63
+217% +$10.3K 0.01% 1341
2018
Q1 		$14K Buy
29
+13
+81% +$1.91K ﹤0.01% 3699
2017
Q4 		$2K Sell
16
-40
-71% -$5.55K ﹤0.01% 5199
2017
Q3 		$9K Sell
56
-61
-52% -$9.22K ﹤0.01% 3868
2017
Q2 		$84K Buy
117
+70
+149% +$10.7K ﹤0.01% 1907
2017
Q1 		$28K Sell
47
-49
-51% -$6.38K ﹤0.01% 2915
2016
Q4 		$11K Sell
96
-7
-7% -$780 ﹤0.01% 3653
2016
Q3 		$5K Sell
103
-156
-60% -$21K ﹤0.01% 4277
2016
Q2 		$156K Buy
259
+205
+380% +$30.2K 0.01% 1163
2016
Q1 		$32K Buy
54
+6
+13% +$747 ﹤0.01% 2373
2015
Q4 		$56K Sell
48
-9
-16% -$1.25K ﹤0.01% 1828
2015
Q3 		$51K Sell
57
-60
-51% -$10.3K ﹤0.01% 1979
2015
Q2 		$133K Sell
117
-29
-20% -$5.21K 0.01% 1036
2015
Q1 		$141K Buy
+146
New +$25.1K 0.02% 887

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Simplex Trading's JAZZ Position: Q1 2026 in Review

Simplex Trading sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 3,042 shares — an estimated $532K sold.

Simplex Trading first reported a position in JAZZ in Q4 2014 and held it in 25 quarters. The position peaked at $2.6M in Q1 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Simplex Trading reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 3,042 Jazz Pharmaceuticals shares in Q1 2026, an estimated $532K.
  • Simplex Trading first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 25 quarters.
  • Simplex Trading's Jazz Pharmaceuticals position peaked at $2.6M in Q1 2022.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.